Briasoulis E[au] - Search Results

Year	Number of Results
1994	1
1997	7
1998	3
1999	2
2000	4
2001	6
2002	3
2003	7
2004	12
2005	14
2006	7
2007	14
2008	14
2009	8
2010	8
2011	7
2012	13
2013	14
2014	6
2015	4
2016	6
2017	2
2018	3
2019	1
2020	1
2023	0

1

Profile of pacritinib and its potential in the treatment of hematologic disorders.

Hatzimichael E, Tsolas E, Briasoulis E. Hatzimichael E, et al. Among authors: briasoulis e. J Blood Med. 2014 Aug 19;5:143-52. doi: 10.2147/JBM.S51253. eCollection 2014. J Blood Med. 2014. PMID: 25170285 Free PMC article. Review.

2

Inherited cancer predisposition syndromes in Greece.

Apessos A, Papadopoulou E, Belogianni I, Baratsis S, Triantafillidis JK, Kosmidis P, Karydas E, Briasoulis E, Pisiotis C, Papazisis K, Nasioulas G. Apessos A, et al. Among authors: briasoulis e. Anticancer Res. 2008 Mar-Apr;28(2B):1341-7. Anticancer Res. 2008. PMID: 18505076 Free article. Review.

3

Revisiting bleomycin from pathophysiology to safe clinical use.

Froudarakis M, Hatzimichael E, Kyriazopoulou L, Lagos K, Pappas P, Tzakos AG, Karavasilis V, Daliani D, Papandreou C, Briasoulis E. Froudarakis M, et al. Among authors: briasoulis e. Crit Rev Oncol Hematol. 2013 Jul;87(1):90-100. doi: 10.1016/j.critrevonc.2012.12.003. Epub 2013 Jan 9. Crit Rev Oncol Hematol. 2013. PMID: 23312772 Review.

4

E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy.

Gkogkou P, Peponi E, Ntaskagiannis D, Murray S, Demou A, Sainis I, Ioakeim E, Briasoulis E, Tsekeris P. Gkogkou P, et al. Among authors: briasoulis e. In Vivo. 2020 Jan-Feb;34(1):453-459. doi: 10.21873/invivo.11795. In Vivo. 2020. PMID: 31882513 Free PMC article.

5

Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update.

Hatzimichael E, Lagos K, Sim VR, Briasoulis E, Crook T. Hatzimichael E, et al. Among authors: briasoulis e. EXCLI J. 2014 Aug 26;13:954-76. eCollection 2014. EXCLI J. 2014. PMID: 26417314 Free PMC article. Review.

6

Targeting oncogenic protein-protein interactions by diversity oriented synthesis and combinatorial chemistry approaches.

Tzakos AG, Fokas D, Johannes C, Moussis V, Hatzimichael E, Briasoulis E. Tzakos AG, et al. Among authors: briasoulis e. Molecules. 2011 May 27;16(6):4408-27. doi: 10.3390/molecules16064408. Molecules. 2011. PMID: 21623312 Free PMC article. Review.

7

The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis.

Benetatos L, Hatzimichael E, Londin E, Vartholomatos G, Loher P, Rigoutsos I, Briasoulis E. Benetatos L, et al. Among authors: briasoulis e. Cell Mol Life Sci. 2013 Mar;70(5):795-814. doi: 10.1007/s00018-012-1080-8. Epub 2012 Jul 24. Cell Mol Life Sci. 2013. PMID: 22825660 Review.

8

Cancers of unknown primary site: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Briasoulis E, Pavlidis N, Felip E; ESMO Guidelines Working Group. Briasoulis E, et al. Ann Oncol. 2009 May;20 Suppl 4:154-5. doi: 10.1093/annonc/mdp159. Ann Oncol. 2009. PMID: 19454441 Free article. Review. No abstract available.

9

Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs.

Sainis I, Fokas D, Vareli K, Tzakos AG, Kounnis V, Briasoulis E. Sainis I, et al. Among authors: briasoulis e. Mar Drugs. 2010 Mar 15;8(3):629-57. doi: 10.3390/md8030629. Mar Drugs. 2010. PMID: 20411119 Free PMC article. Review.

10

Metronomic chemotherapy beyond misconceptions.

Hatzimichael E, Briasoulis E. Hatzimichael E, et al. Among authors: briasoulis e. Haematologica. 2013 Nov;98(11):e145. doi: 10.3324/haematol.2013.096917. Haematologica. 2013. PMID: 24186318 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results